knowledge -WSS

knowledge

author：fashion 2025-09-03 05:40:08 - browse：19

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Caitlin Bernard's story shows physicians can't shy from advocacy

hotspot

WSS

Longer MASH drug regimen improved liver, Akero study finds

Stem cell biologist probes earliest stages of human development

Lack of health data on LGBTQ+ people has serious consequences

For AI in health care standards, federal regulators join with industry group

What to know about Saharan dust affecting the US and how it can affect health

A double vaccine crisis is endangering millions of children

focus

knowledge

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Wildfire smoke exposes gaps in outdoor worker protections

Providers still hesitate to prescribe buprenorphine, study finds

Malaria cases in Florida and Texas: Here’s what you need to know

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Moonlake's readout produced a cash windfall. Risks remain

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

As demand for Covid shots wanes, Moderna seeks its next success

Court strikes down limits on filming of police in Arizona

entertainment

Florida health officials providing scant details on measles cases

Florida health officials providing scant details on measles cases

Microsoft's Peter Lee: Generative AI could help doctors be more human

Medicare drug price negotiation continues, as pharma counteroffers

Fetal cell organoids grown from amniotic fluid, study finds

The public health thinking behind the CDC’s new Covid guidance

leisure time

hotspot

hotspot

entertainment